Peroxisome Proliferator-Activated Receptors and Acute Lung Injury
Open Access
- 8 July 2007
- journal article
- review article
- Published by Hindawi Limited in PPAR Research
- Vol. 2007, 1-8
- https://doi.org/10.1155/2007/63745
Abstract
Peroxisome proliferator-activated receptors are ligand-activated transcription factors belonging to the nuclear hormone receptor superfamily. PPARs regulate several metabolic pathways by binding to sequence-specific PPAR response elements in the promoter region of target genes, including lipid biosynthesis and glucose metabolism. Recently, PPARs and their respective ligands have been implicated as regulators of cellular inflammatory and immune responses. These molecules are thought to exert anti-inflammatory effects by negatively regulating the expression of proinflammatory genes. Several studies have demonstrated that PPAR ligands possess anti-inflammatory properties and that these properties may prove helpful in the treatment of inflammatory diseases of the lung. This review will outline the anti-inflammatory effects of PPARs and PPAR ligands and discuss their potential therapeutic effects in animal models of inflammatory lung disease.Keywords
This publication has 54 references indexed in Scilit:
- Role of peroxisome proliferator‐activated receptor‐α in acute pancreatitis induced by ceruleinImmunology, 2006
- ROLE OF ENDOGENOUS AND EXOGENOUS LIGANDS FOR THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α IN THE DEVELOPMENT OF BLEOMYCIN-INDUCED LUNG INJURYShock, 2005
- The role of peroxisome proliferator-activated receptor-β/δ in epithelial cell growth and differentiationCellular Signalling, 2005
- Effect of rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2on bleomycin-induced lung injuryEuropean Respiratory Journal, 2005
- Peroxisome proliferator‐activated receptor γ: the more the merrier?European Journal of Clinical Investigation, 2005
- Peroxisome Proliferator-activated Receptor- as a Regulator of Lung Inflammation and RepairProceedings of the American Thoracic Society, 2005
- Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces the development of nonseptic shock induced by zymosan in mice*Critical Care Medicine, 2004
- Peroxisome proliferator‐activated receptor‐γ (PPAR‐γ) activation suppresses ischemic induction of Egr‐1 and its inflammatory gene targetsThe FASEB Journal, 2002
- Identification of Nuclear Receptor Corepressor as a Peroxisome Proliferator-activated Receptor α Interacting ProteinPublished by Elsevier ,1999
- Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cellsBiochemical and Biophysical Research Communications, 1989